Management of patients with metastatic colorectal cancer, in particular those with liver
metastases, involves the convergence of multiple medical specialties and treatment …

Since the last two decades, the management of colorectal liver metastases has significantly
improved. This evolution has been made possible through the combination of targeted …

Colorectal cancer is one of the most common solid tumors affecting people around the
world. A significant proportion of patients with colorectal cancer will develop or will present …

Colorectal cancer is the third most common malignancy in Western countries (1). Liver
metastases are present at diagnosis in 15-25% of patients and will develop in a further 60 …

INTRODUCTION—The liver is the dominant metastatic site for patients with colorectal
cancer (CRC), and although two-thirds of affected patients have extrahepatic spread, some …

Colorectal cancer is one of the leading causes of death in the Western world; its incidence is
lower only than those of breast cancer in women and lung cancer in men. Radical surgery …

Surgical removal of all known disease is the only therapy that has any major possibility to
cure a patient with liver metastases from a colorectal cancer. Whether the cured fraction can …

The liver is the most common site of metastases in patients with colorectal cancer (CRC),
and hepatic metastases are responsible for fatalities in at least two thirds of patients with …

Therapeutic management of metastatic colorectal cancer continues to be rapidly changing.
Several papers highlighted possible new treatment modalities during this year's ASCO. A …

Abstract Purpose of Review To describe the main components of modern treatment for
colorectal cancer (CRC) metastatic to the liver. Recent Findings Liver metastasis occurs in …